Literature DB >> 32518951

Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome.

Qian Zhang1, Elena J Orlando2, Hong Y Wang1, Agata M Bogusz1, Xiaobin Liu1, Simon F Lacey3, Honore T Strauser1, Selene Nunez-Cruz1, Reza Nejati3, Paul Zhang1, Sarah Brooks1, Christopher Watt1, J Joseph Melenhorst4, Carl H June1,4, Stephen J Schuster5, Mariusz A Wasik1,3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32518951      PMCID： PMC7582558          DOI： 10.1182/blood.2020005123

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  Histiocytic sarcoma arising from clonally related mantle cell lymphoma.

Authors:  Michelle C Hure; Christopher P Elco; David Ward; Lloyd Hutchinson; Xiuling Meng; David M Dorfman; Hongbo Yu
Journal:  J Clin Oncol       Date:  2011-12-19       Impact factor: 44.544

2.  Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Authors:  Stephen J Schuster; Michael R Bishop; Constantine S Tam; Edmund K Waller; Peter Borchmann; Joseph P McGuirk; Ulrich Jäger; Samantha Jaglowski; Charalambos Andreadis; Jason R Westin; Isabelle Fleury; Veronika Bachanova; S Ronan Foley; P Joy Ho; Stephan Mielke; John M Magenau; Harald Holte; Serafino Pantano; Lida B Pacaud; Rakesh Awasthi; Jufen Chu; Özlem Anak; Gilles Salles; Richard T Maziarz
Journal:  N Engl J Med       Date:  2018-12-01       Impact factor: 91.245

Review 3.  Translating RB1 predictive value in clinical cancer therapy: Are we there yet?

Authors:  Paola Indovina; Francesca Pentimalli; Daniele Conti; Antonio Giordano
Journal:  Biochem Pharmacol       Date:  2019-06-07       Impact factor: 5.858

Review 4.  Escape From ALL-CARTaz: Leukemia Immunoediting in the Age of Chimeric Antigen Receptors.

Authors:  Sisi Zheng; Mukta Asnani; Andrei Thomas-Tikhonenko
Journal:  Cancer J       Date:  2019 May/Jun       Impact factor: 3.360

5.  Cutting Edge: ROR1/CD19 Receptor Complex Promotes Growth of Mantle Cell Lymphoma Cells Independently of the B Cell Receptor-BTK Signaling Pathway.

Authors:  Qian Zhang; Hong Y Wang; Xiaobin Liu; Selene Nunez-Cruz; Mowafaq Jillab; Olga Melnikov; Kavindra Nath; Jerry Glickson; Mariusz A Wasik
Journal:  J Immunol       Date:  2019-09-18       Impact factor: 5.422

6.  Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.

Authors:  Andrew G Evans; Paul G Rothberg; W Richard Burack; Scott F Huntington; David L Porter; Jonathan W Friedberg; Jane L Liesveld
Journal:  Br J Haematol       Date:  2015-06-18       Impact factor: 6.998

7.  Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity.

Authors:  Rahul R Aggarwal; David A Quigley; Jiaoti Huang; Li Zhang; Tomasz M Beer; Matthew B Rettig; Rob E Reiter; Martin E Gleave; George V Thomas; Adam Foye; Denise Playdle; Paul Lloyd; Kim N Chi; Christopher P Evans; Primo N Lara; Felix Y Feng; Joshi J Alumkal; Eric J Small
Journal:  Mol Cancer Res       Date:  2019-03-27       Impact factor: 5.852

8.  Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.

Authors:  Liang Zhang; Yixin Yao; Shaojun Zhang; Yang Liu; Hui Guo; Makhdum Ahmed; Taylor Bell; Hui Zhang; Guangchun Han; Elizabeth Lorence; Maria Badillo; Shouhao Zhou; Yuting Sun; M Emilia Di Francesco; Ningping Feng; Randy Haun; Renny Lan; Samuel G Mackintosh; Xizeng Mao; Xingzhi Song; Jianhua Zhang; Lan V Pham; Philip L Lorenzi; Joseph Marszalek; Tim Heffernan; Giulio Draetta; Philip Jones; Andrew Futreal; Krystle Nomie; Linghua Wang; Michael Wang
Journal:  Sci Transl Med       Date:  2019-05-08       Impact factor: 17.956

9.  Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.

Authors:  Florian T Merkle; Sulagna Ghosh; Nolan Kamitaki; Jana Mitchell; Yishai Avior; Curtis Mello; Seva Kashin; Shila Mekhoubad; Dusko Ilic; Maura Charlton; Genevieve Saphier; Robert E Handsaker; Giulio Genovese; Shiran Bar; Nissim Benvenisty; Steven A McCarroll; Kevin Eggan
Journal:  Nature       Date:  2017-04-26       Impact factor: 49.962

10.  Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells.

Authors:  Qian Zhang; Hong Y Wang; Xiaobin Liu; Michael H Roth; Alex A Shestov; Seung-Cheol Lee; Kanika Jain; Craig Soderquist; Qun-Bin Xiong; Marco Ruella; Honore Strauser; Jerry D Glickson; Stephen J Schuster; Andrzej Ptasznik; Mariusz A Wasik
Journal:  Front Oncol       Date:  2019-07-03       Impact factor: 6.244
View more
  4 in total

Review 1.  CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

Authors:  Katsiaryna Marhelava; Marta Krawczyk; Malgorzata Firczuk; Klaudyna Fidyt
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

2.  Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.

Authors:  Ichiro Kawashima; Naoki Oishi; Kazunari Kasai; Tomohiro Inoue; Eriko Hosokawa; Ayato Nakadate; Minori Matsuura; Takuma Kumagai; Megumi Koshiishi; Takeo Yamamoto; Kei Nakajima; Masaru Tanaka; Tetsuo Kondo; Keita Kirito
Journal:  Virchows Arch       Date:  2021-07-06       Impact factor: 4.064

3.  Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Authors:  Hui Liu; Qi Shen; Chung-Che Chang; Shimin Hu
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

Review 4.  Born to survive: how cancer cells resist CAR T cell therapy.

Authors:  Jean Lemoine; Marco Ruella; Roch Houot
Journal:  J Hematol Oncol       Date:  2021-11-22       Impact factor: 23.168
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.